Consistency of response across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials

被引：0
|
作者：
Blauvelt, Andrew [1 ]
Reich, Kristian [2 ]
Papp, Kim A. [3 ]
Griffiths, Christopher E. M. [4 ]
Armstrong, April W. [5 ]
Foley, Peter [6 ,7 ]
Shen, Yaung-Kaung [8 ]
Kimball, Alexa B. [9 ]
Gordon, Kenneth B. [10 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] K Papp Clin Res & Prob Res Inc, Waterloo, ON, Canada
[4] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp, Dermatol Ctr, Manchester, Lancs, England
[5] Univ Southern Calif, Los Angeles, CA USA
[6] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia
[7] Skin & Canc Fdn Inc, Carlton, Vic, Australia
[8] Janssen Res & Dev LLC, Raritan, NJ USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA USA
[10] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4895
引用
收藏
页码：AB83 / AB83
页数：1
相关论文
共 50 条
  • [31] Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment
    Blauvelt, Andrew
    Gordon, Kenneth B.
    Griffiths, Christopher E. M.
    Papp, Kim A.
    Foley, Peter
    Song, Michael
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Ramachandran, Paraneedharan
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB174 - AB174
  • [32] Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
    Reich, K.
    Papp, K. A.
    Armstrong, A. W.
    Wasfi, Y.
    Li, S.
    Shen, Y. K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1039 - 1049
  • [33] Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2
    Reich, Kristian
    Song, Michael
    Li, Shu
    Jiang, Jingzhi
    Youn, Sang Woong
    Tsai, Tsen-Fang
    Choe, Yong Beom
    Huang, Yu-Huei
    Gordon, Kenneth B.
    JOURNAL OF DERMATOLOGY, 2019, 46 (12): : 1141 - 1152
  • [34] Maintenance of response with guselkumab of up to 3 years' treatment: Voyage 1 trial of patients with plaque psoriasis
    Griffiths, C.
    Papp, K.
    Song, M.
    Randazzo, B.
    Li, S.
    Shen, Y.
    Han, C.
    Blauvelt, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 45 - 45
  • [35] Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2
    Armstrong, A.
    Eyerich, K.
    Conrad, C.
    Zhu, Y.
    Yang, Y. -w.
    Miller, M.
    You, Y.
    Shen, Y. -k.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1375 - E1379
  • [36] Prognostic factors for early PASI 100 response in psoriasis patients treated with guselkumab: Results from the GUIDE study
    Schakel, Knut
    Reich, Kristian
    Asadullah, Khusru
    Pinter, Andreas
    Jullien, Denis
    Weisenseel, Peter
    Paul, Carle
    Gomez, Mario
    Wegner, Sven
    Personke, Yvonne
    Eyerich, Kilian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB195 - AB195
  • [37] CLINICAL RESPONSE AFTER GUSELKUMAB TREATMENT AMONG ADALIMUMAB PASI 90 NON-RESPONDERS: RESULTS FROM THE VOYAGE 1 AND 2 TRIALS
    Griffith, Christopher
    Radtke, Marc Alexander
    Youn, Sang Woong
    Bissonnette, Robert
    Song, Michael
    Wasfi, Yasmine
    Randazzo, Bruce
    You, Yin
    Shen, Yaung-Kaung
    Strober, Bruce
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 20 - 20
  • [38] Efficacy of guselkumab in difficult-to-treat psoriasis regions: Data from VOYAGE 1 and VOYAGE 2 Asian subpopulations
    Jo, Seong Jin
    Huang, Yu-Huei
    Tsai, Tsen-Fang
    Kim, Byung Soo
    Reich, Kristian
    Saadoun, Carine
    Chang, Chia-Ling
    Yang, Ya-Wen
    Youn, Sang Woong
    JOURNAL OF DERMATOLOGY, 2023, 50 (09): : 1180 - 1189
  • [39] FOUR-YEAR EFFICACY AND SAFETY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH AND WITHOUT PSORIATIC ARTHRITIS: A POOLED ANALYSIS FROM VOYAGE 1 AND VOYAGE 2
    Reich, K.
    Dutz, J.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Miller, M.
    You, Y.
    Li, S.
    Shen, Y. K.
    Armstrong, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1673 - 1673
  • [40] Long-term efficacy and safety of guselkumab in psoriasis patients with and without psoriatic arthritis: A pooled analysis from VOYAGE 1 and VOYAGE 2
    Kimball, A. B.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Li, S.
    Fakharzadeh, S.
    Shen, Y. -K.
    Armstrong, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB233 - AB233
12345